Simple Summary Hematological malignancies are diseases involving the abnormal
production of blood cells. The aim of the study is to collect comprehensive information on …

Angioimmunoblastic T-cell lymphoma (AITL) is an uncommon subtype of mature peripheral
T-cell lymphoma (PTCL). The history of AITL is much longer and deeper than the literature …

Background For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline
treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or …

Background Based on the encouraging activity and manageable safety profile observed in a
phase 1 study, the ECHELON-2 trial was initiated to compare the efficacy and safety of …

Traditional views of nutritional carcinogenesis depend on the identification of exogenous
carcinogens as major risk factors. As our understanding evolves, it is clear that the pattern of …

The Activator Protein-1 (AP-1) transcription factor (TF) family, composed of a variety of
members including c-JUN, c-FOS and ATF, is involved in mediating many biological …

The incidence of lymphoma has gradually increased over previous decades, and it ranks
among the ten most prevalent cancers worldwide. With the development of targeted …

Non-Hodgkin's lymphoma (NHL) is a cancer that starts in the lymphatic system. In NHL, the
important part of the immune system, a type of white blood cells called lymphocytes become …

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative
disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas …

Peripheral T-cell lymphoma, not otherwise specified, is a broad category of biologically and
clinically heterogeneous diseases that cannot be further classified into any other of the …